scholarly journals Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study

2018 ◽  
Vol 9 (12) ◽  
pp. 1754-1762 ◽  
Author(s):  
Di Zhang ◽  
Chufeng Zhang ◽  
Jiaqi Huang ◽  
Yan Guan ◽  
Qisen Guo
Keyword(s):  
Lung Cancer ◽  
Retrospective Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Clinical Investigation ◽  
Small Cell ◽  
Second Line ◽  
Chemotherapy Treatment ◽  
Small Cell Lung ◽  
Line Chemotherapy

Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer

2006 ◽  
Vol 7 (6) ◽  
pp. 401-405 ◽  
Author(s):  
Carmelo Tibaldi ◽  
Ilaria Bernardini ◽  
Antonio Chella ◽  
Francesa Russo ◽  
Enrico Vasile ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Stage ◽  
Second Line ◽  
Small Cell Lung ◽  
Line Chemotherapy ◽  
Modified Schedule

Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy

2021 ◽  
pp. canres.CAN-21-2964-E.2021
Author(s):  
Alvaro Quintanal-Villalonga ◽  
Hirokazu Taniguchi ◽  
Yuan Hao ◽  
Andrew Chow ◽  
Yingqian A Zhan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

2003 ◽  
Vol 35 (4) ◽  
pp. 294-298
Author(s):  
Yoon Jae Kim ◽  
Joo Hyuk Sohn ◽  
Chul Kim ◽  
Yong Tai Kim ◽  
Hai Jin Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document